Trepo - Selaus tekijän mukaan "Hugosson, Jonas"
Viitteet 1-7 / 7
-
European Study of Prostate Cancer Screening: 23-Year Follow-up
(30.10.2025)
articleBACKGROUND The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because deaths from ... -
Impact of cancer screening on metastasis: A prostate cancer case study
(2021)
article<p>Background: Trials of cancer screening present results in terms of deaths prevented, but metastasis is also a key endpoint that screening seeks to prevent. We developed a framework for projecting overall (de novo ... -
Prostate cancer mortality in areas with high and low prostate cancer incidence
(2014)
articleBACKGROUND: The effect of prostate-specific antigen (PSA) screening on prostate cancer mortality remains debated, despite evidence from randomized trials. We investigated the association between prostate cancer incidence, ... -
Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps
(20.04.2023)
reviewarticleLong-term screening with serum prostate-specific antigen (PSA) and systematic prostate biopsies can reduce prostate cancer mortality but leads to unacceptable overdiagnosis. Over the past decade, diagnostic methods have ... -
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer
(07 / 2024)
articleObjective: To evaluate whether a subgroup of men can be identified that would benefit more from screening than others. Materials and Methods: This retrospective cohort study was based on three European Randomised Study of ...
